CCM Concord Medical Corp: Price-to-Projected Revenue Ratio
The reliability of Concord Medical Services (CCM) is guaranteed by an extensive network of oncology centers in China equipped with autonomous power supplies. P/S expectations for Concord Medical Services (CCM), as illustrated by this chart on GURU.Markets, confirm this, with the current metric standing at 0.20. Management's strategic vector is focused on the expansion of high-tech radiation therapy, complemented by strict radiation safety controls and environmental compliance during equipment disposal.
Summary analytical data breakdowns for Concord Medical Corp (CCM)
- market price and analyst price targets:
- company stock capitalization data:
- book value of equity indicators:
- debt and solvency information:
Debt to Equity Concord Medical Services|CCM - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Concord Medical Services|CCM - Company Cumulative Debt|Debts to Book Capitalization Concord Medical Corp|CCM - Company Long-Term Indebtedness|Company Short-Term Debts Concord Medical|Quick Ratio concordmedical.com
- financial results and valuation multiples details:
CCM - Net Income|Projected Future Earnings Concord Medical Services|CCM - P/E Multiple|Future Price to Earnings Concord Medical Services Holdings Limited|CCM - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio Concord Medical Corp|CCM - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months Concord Medical|CCM - Net earnings per share for the last four quarters|Quarterly EPS earnings growth concordmedical.com|CCM - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Concord Medical Services
- sales and revenue indicators:
Initial company analysis:Concord Medical CCM
The forward P/S ratio compares the current market value of the business with expected sales volume, allowing for an assessment of the premium or discount relative to future cash flows. For Concord Medical Services (CCM), the expected price-to-sales ratio reflects the market rate for Gamma Knife utilization and government tariffs, turning the price action on this chart into an indicator of medical equipment efficiency.
Competitor analysis for Concord Medical Services
Price-to-Projected Revenue Ratio HCA Healthcare HCA|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|FMS - Price-to-Projected Revenue Ratio|Forward Price to Sales SOLV (Solventum Health)|EHC: Forward P/S Multiple|Market Cap to Projected Revenue UHS|Forward Price-to-Revenue Multiple DVA|RDNT: Forward Price to Sales|Price-to-Projected Revenue Ratio Option Care Health Inc (OPCH)|Forward Price-to-Revenue Multiple Surgery Partners Group SGRY|Forward P/S Multiple PINC (Premier, Inc.)|nationalvision.com (EYE) - Market Cap to Future Revenue Ratio|Progyny - Forward P/S Multiple|ARDT (Ardent Health) - Market Cap to Projected Revenue|SEM: Forward P/S Multiple|ASTH - Market Cap to Expected Sales Ratio|MD (Pediatrix Corp) - Forward P/S Multiple|Forward Price-to-Revenue Multiple US Physical Therapy Inc (USPH)|Forward P/S Multiple PNTG|Forward P/S Multiple Organogenesis Holdings Inc. (ORGO)|Price-to-Projected Revenue Ratio Nutex Health Corp NUTX|Auna Corp - Price-to-Projected Revenue Ratio|SBC: Forward Price-to-Revenue Multiple|Forward Price to Sales EOLS (evolus.com)|Community Health Systems, Inc. (CYH) - Price-to-Projected Revenue Ratio|SKIN - Market Cap to Expected Sales Ratio|MDWD (MediWound Ltd) - Forward P/S Multiple|Market Cap to Future Revenue Ratio Biote Corporation BTMD|Price-to-Projected Revenue Ratio The Joint Corp. (JYNT)|DCGO (docgo.com) - Forward Price to Sales|P3 Health Partners - Forward Price-to-Revenue Multiple|Gain Therapeutics Inc. - Price-to-Projected Revenue Ratio|EUDA Health - Forward P/S Multiple|Market Cap to Expected Sales Ratio Basel Medical Group BMGL|CLGN: Forward P/S Multiple|Forward Price-to-Revenue Multiple cuprina.com.sg|AMS (American Shared Hospital Services) - Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDIROM Healthcare Group Inc. MRM|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|Market Cap to Expected Sales Ratio DIH Group|Forward P/S Multiple XAGE (Longevity Health Holdings)|NIVF - Forward Price-to-Revenue Multiple|ATI Physical Therapy Corp - Forward P/S Multiple|CareMax Inc. (CMAX) - Forward Price-to-Revenue Multiple|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple ModivCare Corp|Forward Price-to-Revenue Multiple NVOS|SSY (SunLink Health Systems, Inc) - Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio IMAC Holdings (BACK)
